Reference Identification

Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis

Ann Rheum Dis, Ferdowsi N, Huq M, Stevens W, Hudson M, Wang M, Tay T, Burchell JL, Mancuso S, Rabusa C, Sundararajan V, Prior D, Proudman SM, Baron M, Nikpour M; Scleroderma Clinical Trials Consortium Damage Index Working Group, The Australian Scleroderma Interest Group, Canadian Scleroderma Research Group. dis 2019; 78:807-816
Country: Australia, Canada
Language: English
https://pubmed.ncbi.nlm.nih.gov/30928903/

Other references of interest

https://minerva-access.unimelb.edu.au/bitstream/handle/11343/213954/Ferdowsi_Nava_thesi_final.pdf?sequence=1&isAllowed=y

Development of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis        

https://pubmed.ncbi.nlm.nih.gov/30906878/

An Interim Report of the Scleroderma Clinical Trials Consortium Working Groups

https://pubmed.ncbi.nlm.nih.gov/33091259/

An Update of Outcome Measures in Systemic Sclerosis.

Instrument/Tool Translations References

---